Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Republic of Korea.
BMC Neurol. 2020 Jul 29;20(1):287. doi: 10.1186/s12883-020-01871-5.
Surgical treatment of anterior communicating artery (Acom) aneurysm is challenging due to anatomic complexity. We aimed to describe our experiences with endovascular treatment (EVT) of Acom aneurysms, and to evaluate the incidence and risk factors of recurrence and retreatment.
The study comprised 260 patients who were treated at a single center between January 2010 and December 2018. Patients who had EVT, including stent-assisted coiling of Acom aneurysms, were included. All medical records were retrospectively reviewed. The incidence and risk factors of recurrence and retreatment were evaluated. Univariate and multivariate analysis were conducted.
Recurrence of Acom aneurysms occurred in 38 (14.6%) patients. Mean follow-up duration was 27 months (range 1-110). Multivariate logistic regression indicated that ruptured aneurysm (odds ratio [OR] 3.55, P = 0.001), dome direction (anterior) (OR 3.86, P = 0.002), maximal diameter (OR 1.19, P = 0.02), and mean age (OR 0.96, P = 0.02) were independent risk factors for aneurysm recurrence. Of 38 cases of recurrence, 10 (3.8%) patients underwent retreatment. Ruptured aneurysm (OR 14.7, P = 0.004), maximal diameter (OR 1.56, P = 0.02), inflow angle (OR 1.04, P = 0.03), and Raymond-Roy classes II and III (OR 6.19, P = 0.03) showed significant relation to retreatment in multivariate logistic regression analysis.
In our study, recurrence rate of Acom aneurysms after EVT was 14.6%. Rupture, anterior dome direction, maximal diameter, and mean age were significantly associated with recurrence. Retreatment rate of recurrent Acom aneurysms after EVT was 3.8%. Patients with Acom aneurysms with large inflow, rupture, large size, or incomplete occlusion may be at a high risk of retreatment of recurring aneurysm.
由于解剖结构复杂,前交通动脉(Acom)动脉瘤的外科治疗具有挑战性。我们旨在描述我们在 Acom 动脉瘤血管内治疗(EVT)方面的经验,并评估复发和再治疗的发生率和危险因素。
这项研究包括 2010 年 1 月至 2018 年 12 月在一家中心接受治疗的 260 名患者。包括支架辅助 Acom 动脉瘤线圈栓塞术在内的 EVT 患者均被纳入。所有病历均进行回顾性分析。评估了复发和再治疗的发生率和危险因素。进行了单变量和多变量分析。
38 名(14.6%)患者的 Acom 动脉瘤复发。平均随访时间为 27 个月(范围 1-110)。多变量逻辑回归表明,破裂的动脉瘤(比值比[OR]3.55,P=0.001)、瘤顶方向(前)(OR3.86,P=0.002)、最大直径(OR1.19,P=0.02)和平均年龄(OR0.96,P=0.02)是动脉瘤复发的独立危险因素。在 38 例复发病例中,10 例(3.8%)患者接受了再治疗。破裂的动脉瘤(OR14.7,P=0.004)、最大直径(OR1.56,P=0.02)、流入角(OR1.04,P=0.03)和 Raymond-Roy 分级 II 和 III(OR6.19,P=0.03)在多变量逻辑回归分析中与再治疗有显著关系。
在我们的研究中,Acom 动脉瘤 EVT 后复发率为 14.6%。破裂、前瘤顶方向、最大直径和平均年龄与复发显著相关。Acom 动脉瘤复发后再治疗率为 3.8%。Acom 动脉瘤瘤体较大、破裂、瘤体较大或不完全闭塞的患者,再发动脉瘤再治疗的风险可能较高。